186 related articles for article (PubMed ID: 10675700)
1. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
2. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
Williams RO; Sykora MA; Mahaguna V
AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
[TBL] [Abstract][Full Text] [Related]
3. Photostability of extended-release matrix formulations.
Maggi L; Ochoa Machiste E; Fasani E; Albini A; Segale L; Conte U
Eur J Pharm Biopharm; 2003 Jan; 55(1):99-105. PubMed ID: 12551710
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
5. The influence of vitamin E succinate on the stability of polyethylene oxide PEO controlled release matrix tablets.
Shojaee S; Cumming I; Kaialy W; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():486-92. PubMed ID: 23880087
[TBL] [Abstract][Full Text] [Related]
6. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
7. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
Lee BJ; Ryu SG; Cui JH
Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
[TBL] [Abstract][Full Text] [Related]
8. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
[TBL] [Abstract][Full Text] [Related]
9. Application of similarity factor in development of controlled-release diltiazem tablet.
Peh KK; Wong CF
Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
[TBL] [Abstract][Full Text] [Related]
10. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
Wang MY; Yang YP; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
[TBL] [Abstract][Full Text] [Related]
11. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
Yang YP; Wang MY; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
Nie SF; Liu H; Liu YL; Pan WS
Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
[TBL] [Abstract][Full Text] [Related]
13. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
Zhang N; Zhu JB
Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
[TBL] [Abstract][Full Text] [Related]
15. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC.
Ishikawa T; Watanabe Y; Takayama K; Endo H; Matsumoto M
Int J Pharm; 2000 Jul; 202(1-2):173-8. PubMed ID: 10915941
[TBL] [Abstract][Full Text] [Related]
16. Formulation of biphasic release tablets containing slightly soluble drugs.
Maggi L; Machiste EO; Torre ML; Conte U
Eur J Pharm Biopharm; 1999 Jul; 48(1):37-42. PubMed ID: 10477326
[TBL] [Abstract][Full Text] [Related]
17. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
Gohel MC; Sumitra G M
J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
[TBL] [Abstract][Full Text] [Related]
18. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
Yan G; Li H; Zhang R; Ding D
Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
[TBL] [Abstract][Full Text] [Related]
20. Probing the dynamics of matrix hydration in the presence of electrolytes.
Pillay V; Fassihi R
Drug Deliv; 2001; 8(2):87-92. PubMed ID: 11400867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
